Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
Not Applicable
Active, not recruiting
- Conditions
- Breast Fibroadenoma
- Registration Number
- NCT01331954
- Lead Sponsor
- Theraclion
- Brief Summary
Demonstrate the efficacy of High Intensity Focused Ultrasound in the treatment of the breast fibroadenoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
-
One breast fibroadenoma with diagnosis based on:
- Clinical examination
- Ultrasound image
- For women older than 35 years: mammogram with BI-RADS score < 3
- Histologic confirmation by two independent readers
-
Fibroadenoma size between 1 cm and 3 cm at its largest dimension (measured by ultrasound)
Exclusion Criteria
- Patient pregnant or lactating
- Bi-RADS score > 2 at the mammogram, or microcalcifications within the lesion.
- History of breast cancer or history of laser or radiation therapy to the target breast
- Breast implants
- Breast cyst
- Fibroadenoma not clearly visible on the ultrasound images (in B mode)
- Patient participating in other trials using drugs or devices
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Reduction of breast fibroadenoma volume at ultrasonography 12 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie HIFU-induced ablation in breast fibroadenoma treatment?
How does HIFU compare to surgical excision in treating breast fibroadenomas in terms of efficacy and recurrence rates?
Which biomarkers correlate with favorable outcomes following HIFU therapy for breast fibroadenomas?
What are the long-term adverse event profiles associated with HIFU treatment for breast fibroadenomas?
Are there combination therapies involving HIFU and pharmacological agents for fibroadenoma management?
Trial Locations
- Locations (1)
University Hospital of Endocrinology (USBALE) "Acad. Ivan Penchev"
🇧🇬Sofia, Bulgaria
University Hospital of Endocrinology (USBALE) "Acad. Ivan Penchev"🇧🇬Sofia, Bulgaria